- Home
- MMU vs KOD Comparison
MMU vs KOD Comparison
Compare MMU & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMU
- KOD
- Stock Information
- Founded
- MMU 1992
- KOD 2009
- Country
- MMU United States
- KOD United States
- Employees
- MMU N/A
- KOD N/A
- Industry
- MMU Investment Managers
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MMU Finance
- KOD Health Care
- Exchange
- MMU Nasdaq
- KOD Nasdaq
- Market Cap
- MMU 562.0M
- KOD 454.7M
- IPO Year
- MMU N/A
- KOD 2018
- Fundamental
- Price
- MMU $10.46
- KOD $4.45
- Analyst Decision
- MMU
- KOD Hold
- Analyst Count
- MMU 0
- KOD 4
- Target Price
- MMU N/A
- KOD $8.00
- AVG Volume (30 Days)
- MMU 170.7K
- KOD 347.2K
- Earning Date
- MMU 01-01-0001
- KOD 03-27-2025
- Dividend Yield
- MMU 4.92%
- KOD N/A
- EPS Growth
- MMU N/A
- KOD N/A
- EPS
- MMU N/A
- KOD N/A
- Revenue
- MMU N/A
- KOD N/A
- Revenue This Year
- MMU N/A
- KOD N/A
- Revenue Next Year
- MMU N/A
- KOD N/A
- P/E Ratio
- MMU N/A
- KOD N/A
- Revenue Growth
- MMU N/A
- KOD N/A
- 52 Week Low
- MMU $8.60
- KOD $2.19
- 52 Week High
- MMU $10.45
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- MMU 54.98
- KOD 27.56
- Support Level
- MMU $10.25
- KOD $4.85
- Resistance Level
- MMU $10.56
- KOD $5.53
- Average True Range (ATR)
- MMU 0.08
- KOD 0.39
- MACD
- MMU 0.00
- KOD -0.05
- Stochastic Oscillator
- MMU 65.63
- KOD 1.03
About MMU Western Asset Managed Municipals Fund Inc.
Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. It predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations). Under normal market conditions, a majority of its total assets are invested in municipal obligations rated investment grade at the time of investment.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.